-- Preview Email Newsletter
| Public Policy Tipoffs Involving Georgia Newsletter for 2024-12-17 ( 3 items ) |
|
American Cancer Society Advances in Oncology- 2024 Research Highlights (10)
ATLANTA, Georgia, Dec. 16 [Category: Medical] -- The American Cancer Society issued the following news release:
December 16, 2024 Scientists at the American Cancer Society (ACS) continued to set the standard for research excellence and innovation in 2024. Important discoveries, including ground-breaking studies such as the VOICES of Black Women(r), are helping to transform cancer treatment and care and improve the lives of cancer patients and their families.
"We're very proud of this new resea more PR
Professor's model perfectly predicted Trump victory (10)
ITHACA, New York, Dec. 16 -- Cornell University issued the following news:
A Cornell professor's election forecasting model correctly picked Trump's win this year in all 50 states and would have correctly predicted 95% of states in every election since 2000.
The model was developed by Peter Enns, professor of government in the College of Arts and Sciences and professor in the Cornell Jeb E. Brooks School of Public Policy, along with Julius Lagodny, Ph.D. '22, and was first deployed in the 2020 more PR
Winship Study Drives FDA Approval for New Leukemia Therapy (10)
ATLANTA, Georgia, Dec. 17 (TNSres) -- Emory University Winship Cancer Institute issued the following news release:
The U.S. Food and Drug Administration (FDA) has approved obecabtagene autoleucel (Aucatzyl, Autolus Inc.) for adults with relapsed or refractory B-cell precursor acute lymphoblastic leukemia (ALL), a fast-growing blood cancer that starts in the bone marrow and affects the body's ability to fight infection. The approval follows results of a landmark study, published in The New Engla more PR
|
